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ABSTRACT 49 
Objectives. With increasing interest in hospital antimicrobial stewardship (AMS) 50 
programmes globally, there is a strong demand for core elements of AMS to be clearly 51 
defined based on principles of effectiveness and affordability. To date, efforts to identify such 52 
core elements have been limited to Europe, Australia, and North America. The aim of this 53 
study was to develop a set of core elements and their related checklist items for AMS 54 
programmes that should be present in all hospitals, regardless of resource availability, 55 
worldwide. 56 
Methods. A literature review was performed by searching Medline and relevant websites to 57 
retrieve a list of core elements and items that could be relevant globally. These core elements 58 
and items were evaluated by an international group of AMS experts using a structured 59 
modified Delphi consensus procedure, using two-phased online in-depth questionnaires. 60 
Results. The literature review identified 7 core elements and their related 29 checklist items 61 
from 48 references. Fifteen experts from 12 countries in 6 continents participated in the 62 
consensus procedure. Ultimately, all 7 core elements were retained, as well as 28 of the initial 63 
checklist items plus 1 that was newly suggested, all with ≥80% agreement; 20 elements and 64 
items were rephrased. 65 
Conclusions. This consensus on core elements for hospital AMS programmes is relevant to 66 
both high and low-to-middle income countries and could facilitate the development of 67 
national AMS stewardship guidelines and adoption by healthcare settings worldwide. 68 
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INTRODUCTION 69 
Antimicrobial resistance, particularly antibiotic resistance in bacteria, is a global 70 
threat, making antimicrobial stewardship (AMS) programmes necessary in all hospitals 71 
worldwide [1–3]. A recent review conducted by ESGAP (ESCMID Study Group for 72 
Antimicrobial stewardship) authors found that many definitions exist for the abbreviation 73 
AMS [2]. The authors suggested that it is best to view the collective daily actions within AMS 74 
as a strategy, and they proposed the following definition: “Antimicrobial stewardship is a 75 
coherent set of actions which promote using antimicrobials in ways that ensure sustainable 76 
access to effective therapy for all who need them” [2]. The absence of a universal definition 77 
for AMS combined with a lack of international guidance and standards are among the many 78 
barriers to the implementation of these programmes globally, especially in low and middle-79 
income countries (LMICs) [2,4]. In North America, Europe, and Australia, collaborative 80 
groups have identified, through a consensual approach, core elements considered essential for 81 
successful AMS programmes [5–9]. These core elements, often bundled into checklists, offer 82 
healthcare providers a pragmatic and measurable means of developing, implementing, and 83 
measuring the impact of hospital AMS programmes. Their applicability, contextual relevance, 84 
and value in other geographies, cultures, and resource settings, particularly LMICs, have not 85 
been previously explored. 86 
Our objective was to identify existing core elements for hospital AMS programmes 87 
and assess their broader global relevance. This was done by undertaking a literature review 88 
followed by a structured consensus procedure involving experts.  89 
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METHODS 90 
Our objective was to identify a set of core elements and their related checklist items 91 
[10], describing the essential and minimum standards for AMS programmes in hospitals 92 
worldwide.  93 
 94 
Group of experts 95 
The steering committee (CP, FB, ASL, AT, SG, RL) invited 15 experts (all other 96 
coauthors) to participate in this study. Experts from different backgrounds (infectious diseases 97 
specialists, clinical microbiologists and clinical pharmacists) were selected based on their 98 
recognized expertise in AMS across various geographic settings in six continents (North 99 
America = 2, South America = 2, Europe = 5, Africa = 2, Asia = 3, Australia = 1), all having 100 
extensive hands-on experience with AMS in LMICs and most of them serving as experts for 101 
health authorities and policy-makers on the AMS topic. 102 
 103 
Literature review and website search 104 
In August–September 2017, the steering committee (six researchers) performed a 105 
narrative literature review of PubMed with the following key words: (antibiotic or 106 
antimicrobial) and stewardship and (review or guidelines or standard or core or checklist), in 107 
addition to a website search (relevant agencies and organizations, such as World Health 108 
Organization (WHO) or European Centre for Disease Prevention and Control (ECDC), to 109 
search for existing core elements for hospital AMS programmes. Only reviews, 110 
guidance/guidelines and consensus documents were included. Additional references were 111 
identified by the 15 experts, with no language restriction (all authors assisted with translation 112 
when required). Data was extracted by two junior researchers and double checked by two 113 
senior researchers. Based on the final list of references [3–50], the steering committee 114 
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compiled summary tables (listing all core elements and checklist items found, with their 115 
corresponding references), which were made available to the experts. CP and SG developed 116 
an initial set of core elements and their related checklist items, to be assessed by the experts, 117 
based on the summary tables, selecting the elements and items they thought might be relevant 118 
worldwide. A core element was defined as a broad category of actions/a strategy within an 119 
AMS programme (e.g. Education), whereas checklist items described specific 120 
actions/interventions within a specific core element. Several checklist items were then listed 121 
under each core element. 122 
 123 
Consensus procedure 124 
The list of core elements and checklist items based on the literature review and the 125 
website search (as well as the detailed summary tables) was presented to the group of 15 126 
experts for a modified Delphi consensus procedure [51], consisting of two surveys (first and 127 
second rounds). Invitation to participate in the survey was sent by email. A teleconference 128 
was organised early November by the steering committee, to explain the objectives and 129 
methods to all experts, and reply to their questions. 130 
For the first round (November 2017), the list of core elements and checklist items 131 
were converted into an internet-based questionnaire using SurveyMonkey (Palo Alto, 132 
California, USA). Respondents were asked to select all core elements and checklist items they 133 
felt were essential worldwide and should be part of AMS programmes in all hospitals and in 134 
all countries, using a “yes/no” option; a “comments” box was provided for each element/item, 135 
including suggestions for rephrasing. Elements and items were (1) selected if agreement was 136 
≥80% (i.e., 12 experts or more); (2) held for reassessment during the second round if 137 
agreement was between 70% and 79% (11 experts); (3) rejected if agreement was <70% 138 
(fewer than 11 experts). Experts were also asked to suggest new elements and items for 139 
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further assessment, in addition to rephrasing. Newly suggested elements and items were 140 
considered for inclusion in the second round if at least three experts made the same 141 
suggestion. 142 
During the second round (December 2017), all previously accepted, newly added, and 143 
rephrased elements and items were presented in a second internet-based questionnaire, which 144 
was sent to all experts who had participated in the first round. Experts were asked to rate the 145 
newly suggested items and the items held for reassessment, as well as to choose the best 146 
phrasing when appropriate (the selected phrasing was the one with >50% agreement). A 147 
“comments” box for open-ended feedback was available for all elements and items. 148 
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RESULTS 149 
Literature review and website search 150 
We identified 48 relevant references (written in Chinese, English, French or Spanish) 151 
[3–50] and came up with an initial set of 7 core elements and 29 checklist items. 152 
 153 
Consensus procedure 154 
All 15 experts participated in the two rounds of the survey. During the first round, all 155 
7 core elements were selected, as well as 27 out of the 29 checklist items, while 1 item was 156 
held for reassessment, 1 was rejected, and 2 additional items were newly suggested by 3 157 
experts. Rephrasing was suggested for 27 elements/items, and comments were added for 14 of 158 
them. During the second round, 2 out of 3 items were selected, and the final phrasing was 159 
decided upon (newly suggested phrasing was chosen in 20 out of 27 cases). The procedure is 160 
summarised in Figure 1, with the final set of 7 core elements and 29 checklist items presented 161 
in Boxes 1 to 7 (Appendix S1 presents the full details of the procedure). The core elements 162 
were as follows: senior hospital management leadership towards AMS (Box 1, 3 checklist 163 
items), accountability & responsibilities (Box 2, 7 items), available expertise on infection 164 
management (Box 3, 2 items), education & practical training (Box 4, 2 items), other actions 165 
aiming at responsible antimicrobial use (Box 5, 8 items), monitoring & surveillance (Box 6, 4 166 
items), and reporting & feedback (Box 7, 3 items).  167 
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DISCUSSION 168 
 Based on a pragmatic literature review and a structured consensus procedure, we 169 
developed minimum core elements and checklist items that could be relevant to hospital AMS 170 
programmes worldwide. Even though most of these checklist items may not currently exist in 171 
most hospitals in low-income countries, we included all of them on the list because our main 172 
objective was to identify universally relevant, essential elements and items based on the best 173 
available evidence. These 7 core elements and their related 29 checklist items could be 174 
adapted and adopted locally depending on factors such as clinical setting and resource 175 
availability. They provide a baseline of key elements required to start hospital AMS 176 
programmes, and could be further modified and used for accreditation/certification, 177 
benchmarking, or scrutiny/performance purposes [52,53]. We were purposely as generic as 178 
possible in the phrasing of elements and items so that countries could adapt them to their own 179 
situations, for example regarding the composition of AMS teams. 180 
 When comparing our 7 core elements and 29 checklist items with the list developed by 181 
the Centers for Disease Control and Prevention (CDC) in the United States, we found that 182 
both lists of core elements are very similar in content, even though the phrasing is different 183 
[6]. The CDC also validated 7 core elements: leadership commitment, accountability, drug 184 
expertise, action, tracking, reporting, and education [6]. The CDC developed a shorter list of 185 
22 related checklist items [6], 12 of them being quite close to the checklist items we selected. 186 
Our list of 29 checklist items is, however, both more comprehensive and more generic, 187 
reflecting our objective of being relevant to any hospital worldwide. 188 
 Implementing AMS programmes in hospitals is one aspect of the comprehensive One 189 
Health strategy needed to tackle antimicrobial resistance [1]. The importance of having such 190 
programmes in the community or primary care setting, that are aligned with hospital 191 
programmes, cannot be underestimated [53]. Implementing a hospital AMS programme is 192 
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also not possible without a strong commitment from policymakers, senior leadership, and 193 
national initiatives to guarantee access to good-quality, equitably priced essential 194 
antimicrobials [54]. In addition, education for the public and health professionals is a 195 
necessary prerequisite to initiating strong and lasting AMS programmes. 196 
 Our work has several limitations. We did not conduct a systematic literature review 197 
but are confident we have not missed significant references, as we have included recent 198 
systematic reviews on the topic, and additional references were identified by a large panel of 199 
AMS experts, with no language restriction [3]. The number of experts involved in the 200 
consensus procedure was relatively small, even though the number was close to previously 201 
published consensus procedures [5,55]. Like all consensus procedures, ours was biased by the 202 
opinions of the experts, who all primarily had the perspective of the steward. Experts who 203 
serve in administrative roles in healthcare and thus represent more of the perspective of a 204 
hospital might have had different answers. 205 
 In conclusion, we propose here an evaluation framework for hospital AMS 206 
programmes that could be relevant across both resource-rich and resource-limited contexts. 207 
Evaluating its value and then its feasibility and measurability in a range of geographic and 208 
resource settings, with a broader stakeholder group should be the next step.  209 
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Box 1. Core element 1: Senior hospital management leadership towards antimicrobial 406 
stewardship 407 
Accompanying comment: This section relates to governance of the programme by hospital 
executives, and specifies how senior hospital management supports the antimicrobial 
stewardship programme. 
Checklist item 1.1: 
Has your hospital management formally identified antimicrobial stewardship as a 
priority objective for the institution and included it in its key performance indicators? 
Checklist item 1.2: 
Is there dedicated, sustainable and sufficient budgeted financial support for 
antimicrobial stewardship activities (e.g., support for salary, training, or IT 
(information technology) support)? 
Checklist item 1.3: 
Does your hospital follow any (national or international) staffing standards for 
antimicrobial stewardship activities (e.g. number of full-time equivalent (FTE) per 100 
beds for the different members of the antimicrobial stewardship team)? 
Accompanying comment: These staffing standards should ideally be set at national level.[56] 
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Box 2. Core element 2: Accountability & responsibilities 409 
Checklist item 2.1: 
Does your hospital have a formal/written antimicrobial stewardship 
programme/strategy accountable for ensuring appropriate antimicrobial use? 
Accompanying comment: This should be based on existing national/international guidelines 
and/or an existing national strategy. 
Checklist item 2.2: 
Does your hospital have a formal organizational multidisciplinary structure responsible 
for antimicrobial stewardship (e.g., a committee focused on appropriate antimicrobial 
use, pharmacy committee, patient safety committee or other relevant structure)? 
Accompanying comment: This antimicrobial stewardship committee can be either stand-
alone or embedded into another committee structure (e.g. pharmacy committee, patient safety 
committee or other relevant structure). In all cases, this antimicrobial stewardship committee 
is explicitly in charge of setting and coordinating the antimicrobial stewardship 
programme/strategy in its mandate/terms of reference. 
Checklist item 2.3: 
Is there a healthcare professional identified as a leader for antimicrobial stewardship 
activities at your hospital and responsible for implementing the programme? 
Checklist item 2.4: 
Is there a document clearly defining roles, procedures of collaboration and 
responsibilities of the antimicrobial stewardship team members? 
Accompanying comment: We refer here to the core operational team of healthcare 
professionals (led by the clinical leader) who will implement the antimicrobial stewardship 
strategy ‘daily on the ground’. This is different from the antimicrobial stewardship committee, 
which is a larger formal organizational structure that includes antimicrobial stewardship 
team members and other relevant professionals and administrators. In resource-limited 
settings or small hospitals, although desirable, it is sometimes difficult to have an 
antimicrobial stewardship team; in that case, the antimicrobial stewardship clinical leader 
will implement the antimicrobial stewardship programme. The composition of the (usually 
multidisciplinary) antimicrobial stewardship team is flexible and should be based on existing 
international recommendations and adapted to the local context. 
Checklist item 2.5: 
Are clinicians, other than those part of the antimicrobial stewardship team (e.g. from 
the ICU, Internal Medicine and Surgery) involved in the antimicrobial stewardship 
committee? 
Checklist item 2.6: 
Does the antimicrobial stewardship committee produce regularly [indicate minimum 
time] a dedicated report which includes e.g. antimicrobial use data and/or prescription 
improvement initiatives, with time-committed short term and long term measurable 
goals/targets for optimising antimicrobial use? 
Checklist item 2.7: 
Is there a document clearly defining the procedures of collaboration of the antimicrobial 
stewardship team/committee with the infection prevention and control team/committee? 
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Box 3. Core element 3: Available expertise on infection management 411 
Checklist item 3.1: 
Do you have access to laboratory/imaging services and to timely results to be able to 
support the diagnosis of the most common infections at your hospital? 
Accompanying comment: A separate checklist on laboratory capacity and presence of quality 
assurance should be developed at national/international level. [49,57] These services can be 
onsite or not. 
Checklist item 3.2: 
In your hospital are there, or do you have access to, trained and experienced healthcare 
professionals (medical doctor, pharmacist, nurse ...) in infection management (diagnosis, 
prevention and treatment) & stewardship willing to constitute an antimicrobial 
stewardship team? 
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Box 4. Core element 4: Education & practical training 413 
Checklist item 4.1: 
Does your hospital offer a range of educational resources to support staff training on 
how to optimise antimicrobial prescribing? 
Accompanying comment: These resources can be developed locally or not, and can use 
multiple formats. 
Checklist item 4.2: 
Do the antimicrobial stewardship team members receive regular training in 
antimicrobial prescribing and stewardship? 
Accompanying comment: This training is usually not offered at the hospital level, but likely 
to be at a regional, national or international level. The hospital should however ensure that 
members of the antimicrobial stewardship team are adequately trained, according to 
local/regional/national requirements. 
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Box 5. Core element 5: Other actions aiming at responsible antimicrobial use 415 
Checklist item 5.1: 
Is a multidisciplinary antimicrobial stewardship team available at your hospital (e.g., 
greater than one trained staff member supporting clinical decisions to ensure 
appropriate antimicrobial use)? 
Checklist item 5.2: 
Does your hospital support the antimicrobial stewardship activities/strategy with 
adequate information technology services? 
Accompanying comment: The level of requirement needs to be defined at 
local/regional/national level. This could include, for example, measurement of antimicrobial 
use. 
Checklist item 5.3: 
Does your hospital have an antimicrobial formulary (i.e. a list of antimicrobials that 
have been approved for use in a hospital, specifying whether the drugs are unrestricted, 
restricted [approval of an antimicrobial stewardship team member is required] or 
permitted for specific conditions)? 
Accompanying comment: This might be based on national recommendations, or the WHO 
Essential Medicines List. 
Checklist item 5.4: 
Does your hospital have available and up-to-date recommendations for infection 
management (diagnosis, prevention and treatment), based on international/national 
evidence-based guidelines and local susceptibility (when possible), to assist with 
antimicrobial selection (indication, agent, dose, route, duration) for common clinical 
conditions? 
Checklist item 5.5: 
Does your hospital have a written policy that requires prescribers to document an 
antimicrobial plan (includes indication, name, dosage, duration, route and interval of 
administration) in the medical record or during order entry for all antimicrobial 
prescriptions? 
Checklist item 5.6: 
Does the antimicrobial stewardship team review/audit courses of therapy for specified 
antimicrobial agents or clinical conditions at your hospital? 
Checklist item 5.7: 
Is advice from antimicrobial stewardship team members easily available to prescribers? 
Checklist item 5.8: 
Are there regular infection and antimicrobial prescribing focused ward rounds in 
specific departments in your hospital? 
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Box 6. Core element 6: Monitoring & surveillance (on a continuous basis) 417 
Checklist item 6.1: 
Does your hospital monitor the quality of antimicrobial use at the unit and/or hospital 
wide level? 
Accompanying comment: This can be done for example by undertaking point prevalence 
surveys or audits, assessing appropriateness of infection management and antimicrobial 
prescription (e.g. indication, choice and duration of antibiotic therapy in pneumonia or 
surgical prophylaxis according to policy/guidance). 
Checklist item 6.2: 
Does your stewardship programme monitor compliance with one or more of the specific 
interventions put in place by the stewardship team (e.g. indication captured in the 
medical record for all antimicrobial prescriptions)? 
Checklist item 6.3: 
Does your hospital monitor antibiotic susceptibility rates for a range of key bacteria? 
Checklist item 6.4: 
Does your hospital monitor the quantity of antimicrobials prescribed/ 
dispensed/purchased at the unit and/or hospital wide level? 
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Box 7. Core element 7: Reporting & feedback (on a continuous basis) 419 
Accompanying comment: All these reports should also be shared with the hospital 
management leadership. 
Checklist item 7.1: 
Does your stewardship programme share hospital-specific reports on the quantity of 
antimicrobials prescribed/dispensed/purchased with prescribers? 
Checklist item 7.2: 
Does your stewardship programme share facility-specific reports on antibiotic 
susceptibility rates with prescribers? 
Checklist item 7.3: 
Are results of audits/reviews of the quality/appropriateness of antimicrobial use 
communicated directly with prescribers? 
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Figure 1. The Delphi consensus procedure: Flow chart 421 
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Literature review 
7 core elements 
29 checklist items 
First survey 
7 core elements and 27 
checklist items selected 
+ 1 checklist item to be 
reassessed 
+ 2 checklist items newly 
suggested 
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Second survey 
2 checklist items selected 
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and 29 checklist items 
